Expedited Partner Therapies for Sexually Transmitted Diseases: Legal and Policy Approaches
4 J. HEALTH & BIOMED. L. 1 (2008)
• James G. Hodge, Jr., J.D., LL.M, Executive Director of the Centers for Law and the Public’s Health: A Collaborative; Associate Professor, Bloomberg School of Public Health, Johns Hopkins University.
• Erin Fuse Brown., J.D., M.P.H., Senior Researcher (former), Centers for Law and the Public’s Health: A Collaborative, Bloomberg School of Public Health, Johns Hopkins University.
• Dhrubajyoti Bhattacharya., J.D., M.P.H., Global Health Law Scholar, LL.M Candidate, Georgetown University Law Center.
• Lindsay F. Wiley., J.D., Senior Researcher (former), Centers for Law and the Public’s Health: A Collaborative, Bloomberg School of Public Health, Johns Hopkins University.
Patient Identifiers and the National Health Information Network: Debunking a False Front in the Privacy Wars
4 J. HEALTH & BIOMED. L. 31 (2008)
• Michael D. Greenberg, J.D., Ph.D., Policy Analyst, RAND Corporation; Research Director, LRN-RAND Center on Corporate Ethics, Law and Governance; Adjunct Professor of Law, University of Pittsburgh School of Law,
• M. Susan Ridgely, J.D., M.S.W., Senior Policy Analyst, RAND Corporation.
Medical Malpractice Reform in Three Southern States
4 J. HEALTH & BIOMED. L. 69 (2008)
• Leonard J. Nelson, III, Professor of Law, Cumberland School of Law, Samford University; Scholar, Lister Hill Center for Health Policy, School of Public Health, University of Alabama at Birmingham.
• Michael Morrisey, Professor, School of Public Health, University of Alabama at Birmingham; Director, Lister Hill Center for Health Policy, School of Public Health, University of Alabama at Birmingham.
• Meredith L. Kilgore, Assistant Professor, School of Public Health, University of Alabama at Birmingham; Scholar, Lister Hill Center for Health Policy, School of Public Health, University of Alabama at Birmingham.
Mental Health Treatment and the Criminal Justice System
4 J. HEALTH & BIOMED. L. 153 (2008)
• Stephen Allen, Suffolk University Law School
Orphan Drug Programs, Public-Private Partnerships and Current Efforts to Develop Treatments for Diseases of Poverty
4 J. HEALTH & BIOMED. L. 193 (2008)
• Daniel Phair, Suffolk University Law School
Case Comments
Terminally Ill Patients do not Have a Fundamental Due Process Right of Access to Investigational Medications That Have Passed Only Phase 1 of the FDA’s Comprehensive Drug Regulation Scheme—Abigail Alliance for Better Access to Developmental Drugs v. Eschenbach
4 J. HEALTH & BIOMED. L. 227 (2008)
• Kristal Ozmun, Suffolk University Law School
Patented Compounds Reasonably Related to Process of Developing Information for Submission to FDA are Exempt From Patent Infringement—Integra Life Sciences v. Merck
4 J. HEALTH & BIOMED. L. 243 (2008)
• Rebecca Jonisch, Suffolk University Law School
